key: cord-1044919-ellrwde0 authors: Richardson, Safiya; Gitlin, Jordan; Kozel, Zachary; Levy, Sera; Rahman, Husneara; Hirsch, Jamie S; McGinn, Thomas; Diefenbach, Michael A title: In-Hospital 30-Day Survival Among Young Adults with COVID-19: A Cohort Study date: 2021-05-07 journal: Open Forum Infect Dis DOI: 10.1093/ofid/ofab233 sha: 2e86458317c58ccf853cc7f77b73832d7c1080b7 doc_id: 1044919 cord_uid: ellrwde0 BACKGROUND: To characterize young adult patients hospitalized with COVID-19 and identify predictors of survival at 30 days. METHODS: This retrospective cohort study took place at 12 acute care hospitals in the New York City area. Patients aged 18-39 hospitalized with confirmed COVID-19 between March 1(st) and April 27(th), 2020 were included in the study. Demographic, clinical and outcome data were extracted from electronic health record reports. RESULTS: 1013 patients were included in the study (median age, 33 years [interquartile range (IQR) 28-36]; 52% female). At the study end point, 940 (92.8%) of patients were discharged alive, 18 (1.8%) remained hospitalized, 5 (0.5%) were transferred to another acute care facility and 50 (4.9%) expired. The most common comorbidities in hospitalized young adult patients were obesity (51.2%), diabetes mellitus (14.8%) and hypertension (13%). Multivariable analysis revealed that obesity (adjusted hazard ratio [aHR], 2.71; 95% CI, 1.28-5.73; p 0.002) and Charlson Comorbidity Index score (aHR, 1.20; 95% CI, 1.07-1.35; p 0.002) were independent predictors of in-hospital 30-day mortality. CONCLUSION: Obesity was identified as the strongest negative predictor of 30-day in-hospital survival in young adults with COVID-19. On December 31, 2019, the World Health Organization was notified about the condition that would later be named coronavirus disease [1] [2] . Estimates of severe disease range from 20% to 30% with case fatality rates ranging from 2% to 7% [3] [4] [5] . The majority of deaths due to COVID-19 have been in patients over 65 years old, who are also more likely to be hospitalized and require treatment in intensive care units [5] . However, this disease has not only afflicted the elderly; young adults are 41% of total COVID-19 cases in both the United States and in New York City in particular [6, 7] . Predictors of mortality for patients of all age groups with COVID-19 have been identified in several studies. Consistent predictors include older age, male sex, and comorbidities, such as hypertension, cardiovascular disease, and diabetes [8] [9] [10] [11] [12] [13] . Studies have also noted obesity as a significant predictor of severe illness, particularly hospitalization [14] [15] [16] . Although these factors may increase mortality risk in young adults, our understanding of COVID-19 in this age group is limited. One research letter describing the clinical outcomes of hospitalized young adults with COVID-19 indicated a mortality rate of 2.7%, with obesity being the strongest risk factor for adverse events [17] . Well-founded concerns about a second wave of COVID-19, and evidence of shifts in differential mortality by demographics in previous pandemics are among many reasons why we must understand predictors of risk and survival in this age group [18] [19] [20] [21] . Our objective was to characterize hospitalized patients aged 18 to 39 and define predictors of 30-day survival in these young adults. Additionally, we characterize hospitalized collegeaged (18 to 24 years) patients. This group is of particular interest considering the inherent infectious disease risk associated with the close social contact that is typical in most college A c c e p t e d M a n u s c r i p t and university settings; more than 12 million individuals worldwide attend college or university every year. Such settings carry significant risk of rapid spread and potential severe disease and mortality [22] . This retrospective cohort study was conducted at 12 hospitals within Northwell Health, the largest academic health system in New York. These acute care facilities are located throughout New York City and the surrounding suburbs of Long Island and Westchester County. The Northwell Health Institutional Review Board approved this study as minimalrisk research using data collected for routine clinical practice and therefore waived the requirement for informed consent. Previous studies have used portions of this cohort of patients however, none examined predictors of mortality in young adults [23] [24] [25] . The study included patients aged 18 to 39 who were sufficiently medically ill to require hospital admission with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by nasopharyngeal polymerase chain reaction testing. The study includes consecutively admitted patients between March 1, 2020, and April 27, 2020. The last day of follow-up was May 12, 2020. Pregnant patients with a length of stay of two days or less were excluded from the study. These patients were admitted for labor and delivery after asymptomatic screening for COVID-19. Data were collected from the enterprise electronic health record (EHR; Sunrise Clinical Manager, Allscripts, Chicago, IL) reporting database. Transfers from one in-system hospital to another were merged and considered as one visit. Transfers out of the system to another acute care facility were considered censored at transfer date. These transfers were conducted A c c e p t e d M a n u s c r i p t to offload high-census hospitals during the peak of the epidemic. Data collected included patient demographic information (age, sex, race, ethnicity, insurance type), body mass index (BMI), smoking status, comorbidities (as captured in the database by International Classification of Disease designation), and outcomes including discharge, length of stay, and death. BMI was categorized into two groups: obese (including all those with a BMI greater than or equal to 30) and non-obese (all those with a BMI less than 30). BMI was recorded for 954 (94.2%) of the patients in the study. Race and ethnicity are recorded by patient selfreport in specified categories. Charlson Comorbidity Index (CCI) was calculated for all patients in the cohort. The CCI predicts 10-year survival probability for patients with multiple comorbidities and was used as a measure of total comorbid burden [26] . Comorbidities in the 16-item CCI include, for example, diabetes, cancer, and congestive heart disease. As the accumulated CCI score increases, the estimated 10-year survival rate decreases. The lowest score of zero on this index typically translates to an estimated 98% 10-year survival rate in general, whereas a score of seven points and above corresponds to a 0% 10-year survival rate. Summary statistics were calculated for the comparison of baseline characteristics and reported as median, along with interquartile range (IQR) or counts with percentages for each category as appropriate. For in-hospital survival, we used the Kaplan-Meier survival curve and extended Cox model, which is an extension of Cox proportional hazards regression model for time-dependent covariates [27] . Age, sex, race, ethnicity, insurance type, obesity, asthma, hypertension, smoking status, and CCI score were included as covariates in the original model. Obesity, asthma, and hypertension were included in the model in addition to A c c e p t e d M a n u s c r i p t CCI score as these medical conditions are not included in the CCI and have been of particular interest in COVID-19. A backward elimination procedure removed sex, hypertension, asthma, smoking status, and insurance type from the final model. Interaction term for Other race with time was included in the model to incorporate violation of proportionality assumption of these two covariates. Data analysis was performed using the statistical software SAS v9.4 (SAS institute, Inc., NC, USA). Results were considered significant if the corresponding p-value was less than 0.05. A total of 1052 patients between the ages of 18 and 39 were admitted during the study period. Of these, 1013 patients were included in the study (median age, 33 years [IQR 28 to 36]; 52% female) and 39 patients were excluded as those admitted for less than two days for labor and delivery after asymptomatic screening for COVID-19. Of the 1013 patients included in the study, 940 (92.8%) were discharged alive, 18 (1.8%) remained hospitalized, five (0.5%) were transferred to another acute care facility, and 50 (4.9%) expired by the study end point. Participant demographics and comorbidities are presented in Table 1 . Median length of stay was 3.85 days (IQR 2.17 to 7.18) for all patients, 3.67 days (IQR 2.13 to 6.88) for patients discharged alive, and 11.84 days (IQR 4.31 to 18.93) for those who expired. The most prevalent age group was 32 to 39. The most common comorbidities for hospitalized patients were obesity (51.2%), diabetes mellitus (14.8%), and hypertension (13%). The median score on the CCI, which does not include obesity, asthma, or hypertension, was zero. A c c e p t e d M a n u s c r i p t There were 105 (10.3%) patients who received treatment with invasive mechanical ventilation (median age, 34.5 [IQR 30 to 37]; 31% female). For these patients, the median length of stay was 4.8 days (IQR 3 to 9.7) as compared to 3.3 days (IQR 2 to 6.8) for those who did not receive invasive mechanical ventilation. The most common comorbidities in this group were obesity (56.2%), diabetes mellitus (31.4%), and hypertension (25.7%). Median score on the CCI was one. Obese patients were not more likely to receive invasive mechanical ventilation, with 11.28% (59/523) of these patients requiring ventilation compared to 8.82% (38/431) of non-obese patients (p<0.210). Eight of the patients who received treatment with invasive mechanical ventilation did not have a recorded body mass index and were left out of this analysis. There were 119 patients in our study within this age group (median age, 22 years [IQR 21 to 23]; 69% female). Median length of stay for these patients was three days (IQR 1.9 to 4.9). Only seven required invasive mechanical ventilation and, of those, four died. Two of the seven who required invasive mechanical ventilation had no prior medical history except for obesity, while the remaining five patients all had comorbidities, including Down's syndrome, congestive heart failure, end-stage kidney disease, and obstructive sleep apnea. The median A c c e p t e d M a n u s c r i p t Obesity and CCI were both negatively associated with in-hospital 30-day survival ( Table 2) . The strongest predictor of mortality in this age group was obesity (Figures 1, 2) . Patients who were obese, as compared to those who were not, were 2.7 times more likely to expire within 30 days. Mortality risk increased by 20% for each additional point on the CCI. Among covariates examined sex, insurance type, asthma, hypertension, and smoking status were eliminated from the final model as these were not associated with increased mortality risk. The hazard ratio for other race varied over time and was significant only in patients with a hospital stay over 20 days. This is the first study to report on predictors of survival in young adults, and its findings are significantly strengthened by our large number of participants. As expected, the overwhelming majority (95%) of hospitalized patients in this age group were alive at the study end point. Obesity, diabetes mellitus, and hypertension were the most common comorbidities in hospitalized patients; these findings echo reports for hospitalized patients of all age groups, and support the findings from study in young adults [17, 23] . BMI and comorbidity burden (as measured by the CCI) were identified as predictors of in-hospital survival in young adults with COVID-19. Obesity emerged as the most significant predictor of mortality in this age group. Obesity does not show a decreased prevalence by age in America, where about 40% of adults in all age groups are obese [28] . With the exception of one patient, with cachexia secondary to metastatic choriocarcinoma, all of the college-aged (18 to 24) patients in our cohort who expired or required invasive mechanical ventilation were obese or morbidly obese. Our findings are supported by a recent study detailing the differential effect of obesity on risk of mortality based on age [29] . That study found that obesity was independently associated with A c c e p t e d M a n u s c r i p t mortality in those younger than 50 with an adjusted odds ratio of 5.1. For those with age above 50 however, the strength of association was weaker, with an adjusted odds ratio of 1.6. We analyzed data only for patients admitted with COVID-19 and were unable to assess for predictors of infection or severe disease in young adults outside of the hospital. However, of the 954 people in our study with a recorded BMI, 519 (54.4%) were obese. This is higher than the national average and average in the NYC metropolitan area and suggests either a higher susceptibility to infections or a higher likelihood of severe disease requiring hospitalization. Further study will assess obesity as a predictor of severe disease and out-ofhospital survival in those with COVID-19. The reason that obesity is associated with mortality in young adults is likely multifactorial. Obesity is associated with several additional chronic medical problems, like diabetes and chronic kidney disease. However, we adjusted for these and other medical conditions in our analysis using the CCI. Obese persons are known to have reduced lung volumes and hypoventilation which makes them at greater risk for complications from respiratory illnesses [30] . Additionally, there is emerging evidence that patients with COVID-19 suffer from a hypercoagulable state that may act synergistically with the hypercoagulable state seen in obesity, which can lead to an increased risk of potentially fatal conditions such as pulmonary embolism, stroke, and arterial thrombosis [31] . Obesity may represent the most significant barrier to survival in young adults hospitalized with this disease. Given these findings and our understanding of obesity as an almost entirely preventable disease, public health recommendations to improve population-level health should include food policy changes in addition to existing diet and lifestyle recommendations. In this study, the impact of obesity on in-hospital survival in young adults was similar in magnitude to the previously reported impact on survival of age over 65 in patients of all ages [10] . None of the funding sources had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The views expressed in this paper are those of the authors and do not represent the views of the National Institutes of Health, the United States Department of Health and Human Services, or any other government entity. The corresponding author confirms that he had full access to all the data in the study and final responsibility for the decision to submit for publication. The lead authors contributed to the planning, conduct, and reporting of the work described in the article, and the Northwell Health COVID-19 Research Consortium contributed to the article's development prior to submission. MD is responsible for the overall content as guarantor. The guarantor accepts full responsibility for the work and/or the conduct of the A c c e p t e d M a n u s c r i p t study, had access to the data, and controlled the decision to publish. The Corresponding Author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors a worldwide licence to the Publishers and its licensees in perpetuity, in all forms, formats, and media (whether known now or created in the future), to (i) publish, reproduce, distribute, display, and store the Contribution; (ii) translate the Contribution into other languages, create adaptations, create reprints, include within collections and create summaries, create extracts, and/or create abstracts of the Contribution; (iii) create any other derivative work(s) based on the Contribution; (iv) exploit all subsidiary rights in the Contribution; (v) include electronic links from the Contribution to third party material wherever it may be located; and (vi) licence any third party to do any or all of the above. All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare no support from any organization for the submitted work, no financial relationships with any organizations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work. The data that support the findings of this study are available on reasonable request from COVID19@northwell.edu. The data are not publicly available due to restrictions as it could compromise the privacy of research participants. This study did not require ethics approval. A c c e p t e d M a n u s c r i p t The manuscript's guarantor affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as originally planned have been explained. Informed consent from human subjects was not required for this study. M a n u s c r i p t Tables Table 1 A c c e p t e d M a n u s c r i p t World Health Organization. Pneumonia of Unknown Cause -China Naming the coronavirus disease (COVID-19) and the virus that causes it Cornavirus Disease 2019 (COVID-19) in Italy Characteristics of and Important Lessons From the COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States Cases in the US COVID-19: Data Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a singlecentered, retrospective study Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Hypertension and Its Severity or Mortality in Coronavirus Disease 2019 (COVID-19): a Pooled Analysis. Polish Archives of Internal Medicine Clinical characteristics and outcomes of patients with severe covid-19 with diabetes Clinical and Laboratory Predictors of In-Hospital Mortality in 305 Patients with COVID-19: A Cohort Study in Wuhan Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation Clinical Outcomes in Young US Adults Hospitalized With COVID-19 Beware of the second wave of COVID-19 pandemic morbidity: The first wave hits the poor, the second wave hits the rich. Influenza Other Respir Viruses Age-specific mortality during the 1918 influenza pandemic: unravelling the mystery of high young adult mortality Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico Total fall enrollment in degree-granting postsecondary institutions, by attendance status, sex of student, and control of institution: Selected years Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the Acute kidney injury in patients hospitalized with COVID-19 COVID-19 in kidney transplant recipients A new method of classifying prognostic comorbidity in longitudinal studies: development and validation Survival analysis CDC. Prevalence of Obesity and Severe Obesity Among Adults: United States Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50 Obesity The obesity hypoventilation syndrome Thrombosis in hospitalized patients with COVID-19 in a New York City health system A c c e p t e d M a n u s c r i p t